Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3
- PMID: 2736747
- DOI: 10.1161/01.cir.80.1.158
Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3
Abstract
In this study, we investigated the role of oxygen-derived free radicals and iron in mediating myocardial injury during ischemia and reperfusion. Iron is of special interest because it may enhance tissue injury during ischemia and reperfusion by catalyzing the formation of highly reactive hydroxyl radicals (by modified Haber-Weiss or Fenton reactions). Rat hearts, perfused by the Langendorff method, were subjected to global ischemia (15 minutes at 37 degrees C) and reperfusion. The effects of two iron chelators, 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and 5-hydroxy-2-hydroxymethyl-4-pyrone (kojic acid), and one antioxidant, (+)-cyanidanol-3, on contractile function, coronary flow, lactate dehydrogenase release, and lactate production were studied. The combination of these iron chelators is of special importance because L1 is known to prevent lipid peroxidation, induced by ADP/Fe3+ and NADPH in microsomes, in contrast to kojic acid. We found significant protection of contractile function (apex displacement) during reperfusion with 50 microM L1 and 20 microM (+)-cyanidanol-3 (p less than 0.01, n = 6), whereas no protection was found with 50 microM kojic acid (n = 6). Measurements of lactate dehydrogenase release during reperfusion showed a protective pattern similar to that found for heart contractile function, although 50 microM kojic acid also showed a significantly lower lactate dehydrogenase release during the first 10 minutes of reperfusion. No differences in coronary resistance or lactate release were found between the various groups. Our findings indicate that iron and oxygen-derived free radicals are important in the pathogenesis of postischemic reperfusion injury probably because of the formation of hydroxyl radicals.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine.Circulation. 1988 Aug;78(2):442-9. doi: 10.1161/01.cir.78.2.442. Circulation. 1988. PMID: 3396180
-
Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.Eur Surg Res. 1992;24(6):349-55. doi: 10.1159/000129227. Eur Surg Res. 1992. PMID: 1338045
-
Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.Circulation. 1987 Oct;76(4):906-15. doi: 10.1161/01.cir.76.4.906. Circulation. 1987. PMID: 2820615
-
Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium.J Cardiovasc Pharmacol. 1992;20 Suppl 5:S25-33. J Cardiovasc Pharmacol. 1992. PMID: 1282610 Review.
-
Prospects for introducing deferiprone as potent pharmaceutical antioxidant.Front Biosci (Elite Ed). 2009 Jun 1;1(1):161-78. doi: 10.2741/E16. Front Biosci (Elite Ed). 2009. PMID: 19482634 Review.
Cited by
-
Synthesis and antioxidant evaluation of some novel ortho-hydroxypyridine-4-one iron chelators.Res Pharm Sci. 2012 Jul;7(3):171-9. Res Pharm Sci. 2012. PMID: 23181095 Free PMC article.
-
Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart.Antioxidants (Basel). 2021 Aug 30;10(9):1390. doi: 10.3390/antiox10091390. Antioxidants (Basel). 2021. PMID: 34573022 Free PMC article. Review.
-
New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine.Antioxidants (Basel). 2025 Aug 10;14(8):982. doi: 10.3390/antiox14080982. Antioxidants (Basel). 2025. PMID: 40867878 Free PMC article. Review.
-
Effects of phytic acid on the myoglobin-t-butylhydroperoxide-catalysed oxidation of uric acid and peroxidation of erythrocyte membrane lipids.Mol Cell Biochem. 1991 Feb 27;101(1):23-9. doi: 10.1007/BF00238434. Mol Cell Biochem. 1991. PMID: 2011117
-
The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases.Pharmaceuticals (Basel). 2023 Jul 18;16(7):1016. doi: 10.3390/ph16071016. Pharmaceuticals (Basel). 2023. PMID: 37513928 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous